Filing Flows › Assembly Biosciences (ASMB) › Recalls, complaints & regulation
Assembly Biosciences (ASMB): clinical trials
Assembly Biosciences (ASMB) beyond its filings: 2 active clinical trials.
Assembly Biosciences' latest quarter
Assembly Biosciences, Q2 2026: revenue $13.4M (+39% year over year), operating margin -47.4%, net loss $3.9M, operating cash flow −$15.5M. The chart follows the revenue to costs, profit and cash.
Questions
How many clinical trials does Assembly Biosciences have?
2 active studies on ClinicalTrials.gov, 0 in phase 3.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.